PER 0.00% 7.8¢ percheron therapeutics limited

CD49d promotes disease progression in chronic lymphocytic leukemia, page-2

  1. 3,229 Posts.
    lightbulb Created with Sketch. 266
    George you could be (should ) spot on :
    quote from ANP ann:
    About ATL1102 ATL1102 is an antisense inhibitor of CD49d, a subunit of VLA-4 (Very Late Antigen-4). Antisense inhibition of VLA-4 expression has demonstrated activity.........
    unquote
    Now we have to wait and see if it will cross Diamond’ s mind or someone else in the management.

    Last edited by imperatore: 26/03/20
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.8¢
Change
0.000(0.00%)
Mkt cap ! $70.32M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 114152 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 203231 1
View Market Depth
Last trade - 08.52am 23/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.